<b>INDEX</b> <li>1. A. M. Risitano, C. Selleri CLONAL NON-MALIGNANT HEMATOLOGICAL DISORDERS: UNRAVELING MOLECULAR PATHOGENIC MECHANISMS TO DEVELOP NOVEL TARGETED THERAPEUTICS. (1-3) <li>2. R. Zambello, A. Teramo, C. Gattazzo, G. Semenzato ARE T-LGL LEUKEMIA AND NK-CHRONIC LYMPHOPROLIFERATIVE DISORDER REALLY TWO DISTINCT DISEASES? (4-11) <li>3. C. Palladino, B. Bruno, M. Boccadoro DISCOVERING THE MEANING OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: CURRENT KNOWLEDGE, FUTURE CHALLENGES. (12-18) <li>4. V. Visconte, C. Selleri, J. P. Maciejewski, R. V. Tiu MOLECULAR PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES. (19-30) <li>5. B Serio, AM Risitano, V Giudice, N Montuori, C Selleri IMMUNOLOGICAL DERANGEMENT IN HYPOCELLULAR MYELODYSPLASTIC SYNDROMES. (31-42) <li>6. A. M Risitano ANTI-COMPLEMENT TREATMENT IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: WHERE WE STAND AND WHERE WE ARE GOING. (43-52) <li>7. A. Tabarroki, R. V. Tiu MOLECULAR GENETICS OF MYELOFIBROSIS AND ITS ASSOCIATED DISEASE PHENOTYPES. (53-64) <li>8. D. Magliacane, R. Parente, M. Triggiani CURRENT CONCEPTS ON DIAGNOSIS AND TREATMENT OF MASTOCYTOSIS. (65-74) <li>9. G. D’Arena, P. Musto MONOCLONAL B-CELL LYMPHOCYTOSIS. (75-79) <li>10. ERRATA CORRIGE

Recent Submissions